further investigations are needed to determine whether differing susceptibility of patients to the effects of lps is due to differences in the endotoxin-neutralizing capacity of their plasma and whether plasma screened for high endotoxin-neutralizing capacity may be therapeutically useful in endotoxemia .
C0023810
lps
C0014264
endotoxin